✨ Exciting News from Pharmidex! ✨
August 26, 2025
We’re delighted to welcome two new colleagues to the
Pharmidex team:
👨🔬
Shaani Ahmed, joining us as a DMPK Junior Scientist, will be supporting our
in vitro and
in vivo ADME studies, helping us continue to deliver high-quality results for our clients.
👩🔬
Ruby Lambert, our new Junior Bioanalyst, will be working alongside the Bioanalysis team to support projects and contribute to the scientific insights that drive our mission forward.
Both Shaani and Ruby bring fresh energy and enthusiasm to
Pharmidex, and we’re excited to support their growth in our collaborative environment.
Please join us in giving them both a very warm welcome to the Pharmidex family! 💜💚
#Pharmidex #DrugDevelopmentServices #PreclinicalResearch #Bioanalysis #DMPK
Head of Respiratory at Pharmidex , Ian Knowles will be attending the Drug Delivery to the Lungs Conference (DDL) on 10–12 December 2025 at the Edinburgh International Conference Centre. DDL brings together global leaders in pulmonary and respiratory drug delivery, and Ian looks forward to meeting fellow attendees, exploring collaborations, and discussing how Pharmidex can support and accelerate drug discovery and development across industry and academia. If you’ll be there too, feel free to reach out we look forward to building new connections and advancing innovation together.
Pharmidex is pleased to announce that Dr. Mo Alavijeh (FRSC, FRSM) and Janette Dalay Robertson will attend the “Recent Clinical Candidates and SMR Award Meeting” this Thursday, 4 December 2025. If you’re attending, we’d be happy to connect!
Pharmidex is pleased to announce that Dr. Mo Alavijeh (FRSC, FRSM) , and our Dr. Ian Knowles , will attend Genesis 2025 this Wednesday, December 3rd, hosted by One Nucleus . They look forward to meeting fellow attendees, exploring new collaborations, and building partnerships with companies and academic groups to advance drug discovery and development. See you at Genesis 2025!
